This offer is redeemable only when accompanied by a valid prescription and is subject to the Terms and Conditions below.
Please click here or scroll down for Indication and Important Safety Information, including Boxed Warning regarding suicidal thoughts and actions. Click here for full Prescribing Information. Click here for the Medication Guide.
BIN# | 019158 |
PCN# | CNRX |
GRP# | |
ID# |
Your APLENZIN Savings Card is now activated!
We will send you a text message to activate your APLENZIN copay card — Reply "Y" to activate your card. You will then receive a text message with a link to add the copay card to the digital wallet on your phone.
Aplenzin Copay Savings Mobile Terms & Conditions
Aplenzin Copay Savings SMS (text) messages are recurring automated copay program messages to receive a digital copay savings card and refill reminders. These SMS messages are sent through PSKW, LLC dba ConnectiveRx, a service provider partner operating on behalf of Bausch Health.
When you opt-in to the service by selecting the radio button and providing your cell phone number, we will send you an SMS message to confirm your signup. By providing your cell phone number, you represent that you are the authorized user of the wireless device you use to receive the messages and that you are authorized to approve any changes. Bausch Health reserves the right to alter these terms and conditions or discontinue the messaging at any time and at its sole discretion, may add or delete a cellular carrier from this program at any time, without notice. Text messages you receive as part of this program are automated and your responses are not read by any person. You are not required to agree to these SMS Terms and Conditions in order to participate in Aplenzin Copay Savings and may opt out at any time. Please visit the Bausch Health privacy policy (https://www.bauschhealth.com/privacy) or contact us for additional information. Please visit the full terms and conditions regarding participation eligibility in Aplenzin Copay Savings (https://www.aplenzin.com).
Message and data rates may apply. While we do not charge you for the messages, your mobile service provider may charge you for SMS text messages as a part of your contract or service. Please contact your mobile service provider for details.
Message frequency varies.
To stop receiving messages, reply STOP at any time.
For help, reply HELP or call 1-844-556-3476.
We are able to deliver on most of the major and minor carriers: i.e., Verizon, Sprint, AT&T, T-Mobile and MetroPCS. If you are unsure whether your carrier supports short codes, please contact your wireless provider directly. Carriers are not liable for delayed or undelivered messages.
TO THE PHARMACIST: When you use the card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription.
For Privacy Statement, please click here. By submitting your information you confirm you have read and agree with the terms of our Privacy Policy and Legal Notice.
Eligibility Criteria/Terms and Conditions: By using the APLENZIN card, you confirm that you understand and agree to comply with the following terms and conditions of this offer:
APLENZIN® (bupropion hydrobromide extended-release tablets) is a prescription medicine used to treat adults with a certain type of depression called major depressive disorder, and for the prevention of autumn-winter seasonal depression (seasonal affective disorder).
WARNING: CHANGES IN THINKING AND BEHAVIOR, DEPRESSION, AND SUICIDAL THOUGHTS OR ACTIONS
Suicidal Thoughts or Actions and Antidepressant Drugs
Antidepressants may increase the risk of suicidal thoughts or actions in some children, teenagers, or young adults within the first few months of treatment. Depression or other serious mental illnesses are the most important causes of suicidal thoughts and actions. People who have (or have a family history of) bipolar illness or suicidal thoughts or actions may have a particularly high risk. Pay close attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if symptoms such as anxiety, irritability, impulsivity, trouble sleeping, aggressive behavior or suicidal thoughts are new, worse or worry you. APLENZIN has not been evaluated for use in patients under the age of 18.
Call your healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:
Although APLENZIN is not a treatment for quitting smoking, it contains the same active ingredient (bupropion) as ZYBAN, which is used to help patients quit smoking.
Some people have had serious side effects while taking bupropion to help them quit smoking, including:
New or worse mental health problems, such as changes in behavior or thinking, aggression, hostility, agitation, depression, or suicidal thoughts or actions. Some people had these symptoms when they began taking bupropion, and others developed them after several weeks of treatment, or after stopping bupropion. These symptoms happened more often in people who had a history of mental health problems before taking bupropion than in people without a history of mental health problems.
Stop taking APLENZIN and call your healthcare provider right away if you, your family, or caregiver notice any of these symptoms. Work with your healthcare provider to decide whether you should continue to take APLENZIN. In many people, these symptoms went away after stopping APLENZIN, but in some people, symptoms continued after stopping APLENZIN. It is important for you to follow-up with your healthcare provider until your symptoms go away.
Before taking APLENZIN, tell your healthcare provider if you have ever had depression or other mental health problems. You should also tell your healthcare provider about any symptoms you had during other times you tried to quit smoking, with or without bupropion.
What Other Important Information Should I Know About APLENZIN?
Do not take APLENZIN if you:
Although APLENZIN is not a treatment for quitting smoking, it contains the same active ingredient (bupropion) as ZYBAN, which is used to help patients quit smoking. Before taking APLENZIN, tell your healthcare provider if you have ever had depression, suicidal thoughts or actions, or other mental health problems or any symptoms you had during other times you tried to quit smoking with or without bupropion. Also, tell your healthcare provider about your other medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Many medicines increase your chances of having seizures or cause other serious side effects if you take them while you are using APLENZIN.
The most common side effects of APLENZIN include: trouble sleeping, stuffy nose, dry mouth, dizziness, feeling anxious, nausea, constipation, and joint aches.
Click here to read the Medication Guide carefully before you start using APLENZIN. If you have any questions about APLENZIN, ask your healthcare provider or pharmacist.
Click here for full Prescribing Information, including Medication Guide and Boxed Warning regarding suicidal thoughts and actions.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also contact Bausch Health Customer Service at 1-800-321-4576.